| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 135.21B | 121.24B | 111.59B | 100.17B | 89.48B |
| Gross Profit | 105.67B | 94.39B | 86.43B | 77.22B | 67.96B |
| EBITDA | 91.52B | 92.77B | 83.61B | 72.73B | 62.22B |
| Net Income | 75.19B | 64.62B | 58.01B | 50.12B | 43.50B |
Balance Sheet | |||||
| Total Assets | 618.80B | 500.38B | 462.17B | 366.71B | 323.93B |
| Cash, Cash Equivalents and Short-Term Investments | 207.38B | 200.06B | 170.24B | 156.32B | 122.70B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 102.78B | 66.52B | 63.47B | 38.84B | 30.36B |
| Stockholders Equity | 516.01B | 433.85B | 398.69B | 327.86B | 293.57B |
Cash Flow | |||||
| Free Cash Flow | 71.53B | 60.73B | 52.10B | 51.84B | 37.15B |
| Operating Cash Flow | 73.75B | 62.79B | 55.83B | 52.96B | 38.97B |
| Investing Cash Flow | -2.02B | -3.93B | -2.21B | 1.28B | -44.05B |
| Financing Cash Flow | -64.40B | -29.04B | -39.70B | -20.62B | -22.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥2.03T | 22.45 | 15.18% | 1.51% | 11.52% | 16.82% | |
77 Outperform | ¥72.04B | 21.08 | 31.71% | 1.68% | 19.53% | 51.63% | |
75 Outperform | ¥1.15T | 17.76 | 38.51% | 1.37% | 6.42% | 4.23% | |
70 Outperform | ¥29.90B | 13.84 | ― | 4.58% | 6.58% | 35.23% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥131.04B | 293.64 | ― | ― | 31.31% | ― | |
54 Neutral | ¥255.08B | 24.12 | -19.16% | ― | 25.36% | ― |